Interestingly, the association between plasma NfL and risk of progressing to clinically-diagnosed DAT became non-significant when the analyses were run including only individuals without cognitive impairment, suggesting that plasma NfL, unlike Aβ42/Aβ40 ratio, becomes altered when cognitive decline is noticeable. This evidence concerns the gene NEFL and Cognitive impairment.